Hormones can influence ovarian cancer growth by stimulating cell proliferation, angiogenesis (formation of new blood vessels) ...

The quest for VEGF and other factors that promote tumour angiogenesis was initiated many decades ago, and a long and complicated path has led to the development of inhibitors of these molecules as ...

On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor ...

Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company ...

KSI-501 clinical program: In the first quarter of 2024 we shared the Phase 1 study results of KSI-501 in patients with diabetic macular edema ("DME") at the Angiogenesis, Exudation, and Degeneration ...

The use of investigational combination therapies to treat erectile dysfunction (ED) had mixed outcomes, according to results from two trials presented here. In the ...

In this report, we will discuss some of the AACR data relating to angiogenesis in light of previous results from clinical trials, attempting to outline what has been achieved so far and what are ...

Received FDA Fast Track Designation for the investigation of CTX-009 in combination with paclitaxel for the treatment of patients with metastatic ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company), a clinical-stage pharmaceutical company with a broad ...

Cancer stem cells (CSCs) are a small subset of adaptive malignant cells that promote tumor growth and drug resistance.

Alchemab Therapeutics, an antibody discovery firm known for identifying natural antibodies in disease-resistant individuals, ...